Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:12:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual content and indicating the resource is restricted.
    Difference
    19%
    Check dated 2026-09-19T22:27:14.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Added the NIH funding identifier '2019 ( U.S. NIH Grant/Contract )' to the study's identifiers and updated the page revision from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T19:34:43.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    There are no additions or deletions to report for this page.
    Difference
    0.0%
    Check dated 2026-08-15T21:53:37.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.4 to v3.6.5, indicating a small platform update rather than a modification to the study details.
    Difference
    0.0%
    Check dated 2026-08-08T19:52:25.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.6.4 has replaced the previous Revision: v3.6.3, indicating a new release version.
    Difference
    0.0%
    Check dated 2026-07-25T12:35:52.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.